Modafinil in children and adolescents with attention-deficit/hyperactivity disorder:a preliminary 8-week, open-label study

References

• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Press, 2000
   Google Scholar
• Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics 2001;108:1033–44
   PubMed Web of Science ®Google Scholar
• Biederman J, Faraone SV. Current concepts on the neurobiology of Attention-Deficit/Hyperactivity Disorder. J Atten Disord 2002;6 (Suppl 1):S7–16
   PubMedGoogle Scholar
• Castellanos FX. Toward a pathophysiology of attention-deficit/hyperactivity disorder. Clin Pediatr (Phila) 1997;36: 381–93
   PubMed Web of Science ®Google Scholar
• Bush G, Frazier JA, Rauch SL, et al. Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop. Biol Psychiatry 1999;45:1542–52
   PubMed Web of Science ®Google Scholar
• Fallgatter AJ, Ehlis AC, Seifert J, et al. Altered response control and anterior cingulate function in attention-deficit/hyperactivity disorder boys. Clin Neurophysiol 2004;115:973–81
   PubMed Web of Science ®Google Scholar
• Liotti M, Pliszka SR, Perez R, et al. Abnormal brain activity related to performance monitoring and error detection in children with ADHD. Cortex 2005;41:377–88
   PubMed Web of Science ®Google Scholar
• Schulz KP, Tang CY, Fan J, et al. Differential prefrontal cortex activation during inhibitory control in adolescents with and without childhood attention-deficit/hyperactivity disorder. Neuropsychology 2005;19:390–402
   PubMed Web of Science ®Google Scholar
• Tamm L, Menon V, Ringel J, et al. Event-related FMRI evidence of frontotemporal involvement in aberrant response inhibition and task switching in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2004;43:1430–40
   PubMed Web of Science ®Google Scholar
• Chemelli RM, Willie JT, Sinton CM, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999;98:437–51
   PubMed Web of Science ®Google Scholar
• Lin JS, Hou Y, Jouvet M. Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proc Natl Acad Sci U S A 1996;93: 14128–33
   Google Scholar
• Scammell TE, Estabrooke IV, McCarthy MT, et al. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 2000;20:8620–8
   PubMed Web of Science ®Google Scholar
• Rugino TA, Copley TC. Effects of modafinil in children with attention-deficit/hyperactivity disorder: an open-label study. J Am Acad Child Adolesc Psychiatry 2001;40:230–5
   PubMed Web of Science ®Google Scholar
• Biederman J, Swanson JM, Wigal SB, et al. A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study. J Clin Psychiatry 2006;67:727–35
   PubMed Web of Science ®Google Scholar
• Columbia University. NIMH DISC-IV Diagnostic Interview Schedule for Children: Interviewer’s Manual. New York: Columbia University, 1999
   Google Scholar
• Wechsler D. Wechsler Intelligence Scale for Children. Third edition. New York, NY: Harcourt Brace Jovanovich, 1992
   Google Scholar
• Psychological Corporation. WIAT Screener Manual. New York: Harcourt Brace Jovanovich, 1992
   Google Scholar
• Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised. US Department of Health, Education, and Welfare Publication (ADM) 76–338. Rockville, MD: National Institute of Mental Health, 1976
   Google Scholar
• DuPaul GJ, Power TJ, Anastopoulos AD, et al. ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation. New York, NY: Guilford Press, 1998
   Google Scholar
• Conners CK. Conners’ Rating Scales – Revised: Technical Manual. North Tonawanda, NY: Multi-Heath Systems, 2000
   Google Scholar
• Conners CK. Rating scales in attention-deficit/hyperactivity disorder: use in assessment and treatment monitoring. J Clin Psychiatry 1998;59 (Suppl 7):24–30
   PubMed Web of Science ®Google Scholar
• Conners CK, Sitarenios G, Parker JD, et al. The revised Conners’ Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity. J Abnorm Child Psychol 1998;26:257–68
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics. Clinical practice guidelines: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics 2000;105:1158–70
   PubMed Web of Science ®Google Scholar
• Rugino TA, Samsock TC. Modafinil in children with attention-deficit hyperactivity disorder. Pediatr Neurol 2003;29:136–42
   PubMed Web of Science ®Google Scholar
• Swanson JM, Greenhill LL, Lopez FA, et al. Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation. J Clin Psychiatry 2006;67:137–47
   PubMed Web of Science ®Google Scholar
• Biederman J, Swanson JM, Wigal SB, et al. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study. Pediatrics 2005;116:e777–84
   PubMed Web of Science ®Google Scholar
• Greenhill LL, Biederman J, Boellner SW, et al. A randomized, double-blind, placebo-controlled study of modafinil in children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2006;45:503–11
   PubMed Web of Science ®Google Scholar
• Owen J, Grasela T, Robertson P, Jr, et al. Population pharmacokinetic/pharmacodynamic profile of modafinil film-coated tablets: therapeutic doses for attention-deficit/hyper-activity disorder. Curr Med Res Opin 2006;In press
   Google Scholar
• Owen J, Grasela T, Robertson PJ, et al. Population pharmacokinetics of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder. American Association of Pharmaceutical Scientists; 2005 November 6–10; Nashville, TN; 2005
   Google Scholar